Streams

New York's Top Earners from Seven Big Pharmaceutical Companies

Thursday, November 18, 2010

This list is based on data released by ProPublica on Oct. 19, 2010. They identified 384 health providers who earned more than $100,000 total from one or more of the following seven companies that have disclosed payments in 2009 and early 2010: Pfizer, Merck, Johnson & Johnson, Eli Lilly, AstraZeneca, Cephalon and GlaxoSmithKline. ProPublica says it matched the payee records with licensed doctors and registered nurses. When a match could not be found, for example when a recipient was a pharmacist, ProPublica used other sources to confirm their identities. Read more about how ProPublica compiled this information here.

NOTE: The data in WNYC's chart does not reflect the latest updated information available November 18, which means some doctors may have dropped off this list, and others may have been added.

If you are a listed practitioner and believe you do not belong in this database, please contact ProPublica at ornstein.weber@propublica.org.

 

A note about this database: Only seven drug companies have publicly disclosed the payments they have made to doctors. Therefore, these physicians comprise only a small percentage of the total number of physicians who get paid to speak for pharmaceutical companies in the U.S. This database only includes data from the following seven companies: Pfizer, Merck, Johnson & Johnson, Eli Lilly, AstraZeneca, Cephalon and GlaxoSmithKline. There are more than 70 pharmaceutical companies in the U.S.

Top Earners in New York

Graphic by Stephen Nessen

Produced by:

Stephen Nessen

Tags:

More in:

The Morning Brief

Enter your email address and we’ll send you our top 5 stories every day, plus breaking news and weather.

Comments [2]

Sue NY

I am a psychiatric nurse practitioner and have attended many of these dinners sponsored by the pharmaceutical companies. I agree that it is risky that a speaker will be influenced to prescribe more of a certain drug if they are on the payroll and it may be that they are pressured behind the scenes to do so. But I have found that these speakers are smart, well educated people and would doubt that is the case. The biggest problem is that they are not allowed to speak from their experience and must read from the script. The reps are present and make sure they say what is expected. Todays comment was correct in that a monkey could read the power point presentations. I have actually stopped going to these dinners as I find them boring and repeatative. The educational levels of the speakers are inconsequential and the pharm companies and would better serve the medical community if they instructed the reps to leave the room after the presentation is complete and allow an open discussion that all would benefit all, not just the speaker who is making extremely good money for doing very little.

Nov. 18 2010 06:42 PM
maria from nj

I am a pharmacist currently employed by the pharmaceutical industry. I don't think today's program served the interest of your audience. It sounds like Ms Chang had had a preconceived point to prove. It was a one sided argument with many flaws.
For example:1. The slide presentation in commercia speaker programs is regulated by strict guidelines that prohibit the inclusion of other information outside the package insert. The discussion of other therapies is not allowed unless a head to head product comparison study was conducted and the results are approved by the FDA.
2.Many times the speakers are academicians and investigators that don't necessarily write a lot of prescriptions. They are experts in a particular specialty
and well respected by their peers. Not at all the unprofessional quacks you portrayed in your program.
The attendees to the program know that it is a commercial event and the purpose is to promote a particular product. For the most part these are highly skilled professionals that can make their own decisions on what is best for their patient.
The US is a world leader in pharmaceutical investigation and most of it is done with funds from big pharma. This industry is dedicated to reasearch products that save and improve human lives. It is also a major source of employment for many americans.
I understand your ethical concern but the cases of abuse and fraud are the exception, not the rule. The listeners of NPR deserve a more objective and fair balanced program

Nov. 18 2010 03:08 PM

Leave a Comment

Email addresses are required but never displayed.

Sponsored

Latest Newscast

 

 

Support

WNYC is supported by the Charles H. Revson Foundation: Because a great city needs an informed and engaged public

Feeds

Supported by